Major Collaborations

• Alwin Kramer, German Cancer Research Center and Dept. of Internal Medicine, University of Heidelberg, Germany. Targeting lymphocytes quiescence as a treatment for T-ALL treatment. Holding a shared grant, German Cancer Research Center (DKFZ)-Israel Ministry of Science & Technology.
• Magdalena Huber, Institute for Medical Microbiology and Hygiene Medicine Marburg University Germany. Role of mitochondrial complex V restriction in responsiveness of naïve CD8 T cells.
• Daniel Popkin, Case Western Reserve University, Cleveland, OH, USA. Role of Slfn2 in T-ALL development. Two joint papers.
• John Parks, Wake Forest School of Medicine, Winston-Salem, NC, USA. Lipid and cholesterol metabolism in T cells. One joint paper.​​